Isabella Bonilha
Campinas, SP 13084971, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Effect of methotrexate on endothelial function in psoriasis patients.
Journal: The Journal of dermatological treatment
Published: May 26, 2026
Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial.
Journal: Cardiovascular diabetology
Published: November 05, 2025
LDL subspecies and lipidome change by evolocumab add-on therapy to empagliflozin in patients with type 2 diabetes: A prespecified secondary analysis of a randomized clinical trial.
Journal: Atherosclerosis
Published: August 19, 2025
Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design.
Journal: Expert opinion on drug safety
Published: October 08, 2024
Diacerein reduces inflammasome activation and SARS-CoV-2 virus replication: a proof-of-concept translational study.
Journal: Frontiers in pharmacology
Published: March 16, 2024
Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial.
Journal: International journal of molecular sciences
Published: February 16, 2024
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction.
High-Density Lipoproteins at the Interface between the NLRP3 Inflammasome and Myocardial Infarction.
Journal: International journal of molecular sciences
Published: December 30, 2023
Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model.
Journal: Health economics review
Published: January 20, 2023
Very low HDL levels: clinical assessment and management.
Journal: Archives of endocrinology and metabolism
Published: January 18, 2023
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19.
Journal: Molecular genetics and metabolism
Published: October 18, 2022
Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial.
Journal: Cardiovascular diabetology
Published: June 29, 2022
Last Updated: 09/26/2026